- Home
- FCO vs THTX Comparison
FCO vs THTX Comparison
Compare FCO & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCO
- THTX
- Stock Information
- Founded
- FCO 1991
- THTX 1993
- Country
- FCO United Kingdom
- THTX Canada
- Employees
- FCO N/A
- THTX N/A
- Industry
- FCO Investment Managers
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- FCO Finance
- THTX Health Care
- Exchange
- FCO Nasdaq
- THTX Nasdaq
- Market Cap
- FCO 78.3M
- THTX 118.2M
- IPO Year
- FCO N/A
- THTX N/A
- Fundamental
- Price
- FCO $6.13
- THTX $2.74
- Analyst Decision
- FCO
- THTX Hold
- Analyst Count
- FCO 0
- THTX 1
- Target Price
- FCO N/A
- THTX N/A
- AVG Volume (30 Days)
- FCO 100.1K
- THTX 6.2M
- Earning Date
- FCO 01-01-0001
- THTX 04-09-2025
- Dividend Yield
- FCO 14.96%
- THTX N/A
- EPS Growth
- FCO N/A
- THTX N/A
- EPS
- FCO 0.43
- THTX N/A
- Revenue
- FCO N/A
- THTX $88,666,000.00
- Revenue This Year
- FCO N/A
- THTX N/A
- Revenue Next Year
- FCO N/A
- THTX $15.13
- P/E Ratio
- FCO $12.30
- THTX N/A
- Revenue Growth
- FCO N/A
- THTX 13.52
- 52 Week Low
- FCO $4.73
- THTX $1.08
- 52 Week High
- FCO $6.63
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- FCO 61.05
- THTX 64.04
- Support Level
- FCO $5.96
- THTX $2.64
- Resistance Level
- FCO $6.24
- THTX $2.97
- Average True Range (ATR)
- FCO 0.13
- THTX 0.16
- MACD
- FCO 0.04
- THTX -0.03
- Stochastic Oscillator
- FCO 74.47
- THTX 56.60
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.